Samsung Biologics Co Ltd banner

Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 999 999.9999 KRW Market Closed
Market Cap: ₩82.3T

P/E

46.1
Current
41%
Cheaper
vs 3-y average of 78.2

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
46.1
=
Market Cap
₩82.3T
/
Net Income (Common)
₩1.8T

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
46.1
=
Market Cap
₩82.3T
/
Net Income (Common)
₩1.8T

P/E Valuation Scenarios

Samsung Biologics Co Ltd is trading below its 3-Year Average

If P/E returns to its 3-Year Average (78.2), the stock would be worth ₩1 695 337.09 (70% upside :side from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-70%
Maximum Upside
+108%
Average Upside
28%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 46.1 ₩1 000 000
0%
3-Year Average 78.2 ₩1 695 337.09
+70%
5-Year Average 96 ₩2 080 412.94
+108%
Industry Average 47.9 ₩1 039 177.77
+4%
Country Average 13.9 ₩300 716.12
-70%

Forward P/E
Today's price vs future Net Income (Common)

Current Market Cap Net Income (Common) Forward P/E
₩82.3T
/
Dec 2025
₩1.8T
=
46.1
Current
₩82.3T
/
Dec 2026
₩1.9T
=
43.6
Forward
₩82.3T
/
Dec 2027
₩2.2T
=
37.2
Forward
₩82.3T
/
Dec 2028
₩2.5T
=
32.9
Forward

Forward P/E shows whether today's P/E still looks high or low once future Net Income (Common) are taken into account.

Peer Comparison

Market Distribution

Samsung Biologics Co Ltd
Glance View

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett